Skip to content

Serotonin research published in 2017

Page 3 of 3: studies 41 to 43 of 43, newest first. Back to the serotonin overview

Studies

Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use Disorder.

Current Topics in Behavioral Neurosciences 2017 Susan Schenk, Dane Aronsen

As is the case with other drugs of abuse, a proportion of ecstasy users develop symptoms consistent with a substance use disorder (SUD). In this paper, we propose that the pharmacology of MDMA, the primary psychoactive component of ecstasy tablets, changes markedly with repeated exposure and that neuroadaptations in dopamine and serotonin brain systems underlie the shift from MDMA use to MDMA...

Longitudinal Examination of Learning and Memory in Rats Following Adolescent Exposure to 3,4-Methylenedioxymethamphetamine or 5-Methoxy-N,N-Diisopropyltryptamine

Journal of Behavioral and Brain Science 2017 David M. Compton, Kerri L. Dietrich, Peniel Esquivel et al. 2 citations

A drug of abuse, Foxy or Methoxy Foxy gained popularity among recreational users as an alternative to MDMA (Ecstasy). Considerable research into the consequences of MDMA use is available, yet much remains unknown about the neurobiological consequences of Foxy use. In addition, research into the long-term neuropsychological repercussions associated with these two compounds remains incomplete....

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways

Current Topics in Behavioral Neurosciences 2017 Juan F López-Giménez, Javier González-Maeso 302 citations

The neuropsychological effects of naturally occurring psychoactive chemicals have been recognized for millennia. Hallucinogens, which include naturally occurring chemicals such as mescaline and psilocybin, as well as synthetic compounds, such as lysergic acid diethylamide (LSD), induce profound alterations of human consciousness, emotion, and cognition. The discovery of the hallucinogenic...